Research & Technology

Spectrum Health Enrolling Patients in Clinical Trial for Inpatient COVID-19 Treatment

Regeneron’s drug REGN-COV2 has shown improved symptoms in non-hospitalized COVID-19 patients.

GRAND RAPIDS Mich., Oct. 29, 2020 – Spectrum Health is partnering with Regeneron Pharmaceuticals to enroll patients into a clinical trial evaluating REGN-COV2, the company’s investigational antibody cocktail for the treatment and prevention of COVID-19.

Spectrum Health is the only health system in West Michigan and one of only two in the state to offer this trial, known as the aSPIKE trial, for hospitalized COVID-19 patients.

“Spectrum Health is participating in a trial to test the drug’s efficacy in hospitalized patients,” said Spectrum Health Research Physician Gordana Simeunovic, MD. “It is a randomized, double-blind trial that measures the effect of adding the drug to the usual standard-of-care treatment we use in our hospital, compared to adding a placebo.”

The trial is actively enrolling patients hospitalized at Spectrum Health Butterworth Hospital in Grand Rapids. To learn more, please contact covid19research@spectrumhealth.org

In addition to the trial in non-hospitalized patients, REGN-COV2 is currently being studied in a Phase 2/3 clinical trial for the treatment of COVID-19 in hospitalized patients, the Phase 3 open-label RECOVERY trial of hospitalized patients in the UK and a Phase 3 trial for the prevention of COVID-19 in household contacts of infected individuals.

Regeneron confirmed that President Trump received a dose of the company’s investigational COVID-19 antibody treatment, REGN-COV2, following a ‘compassionate use’ request from the President’s physicians.

For more information and data about the trial, please visit Regeneron.

 

###

Spectrum Health System, a not-for-profit, integrated health system, is committed to improving the health and wellness of our communities. We live our mission every day with 31,000 compassionate professionals, 4,600 medical staff experts, 3,300 committed volunteers and a health plan serving more than 1 million members. Our talented physicians and caregivers are privileged to offer a full continuum of care and wellness services to our communities through 14 hospitals, including Helen DeVos Children’s Hospital, 150 ambulatory sites and telehealth offerings. We pursue health care solutions for today and tomorrow that diversify our offerings. Locally-governed and based in Grand Rapids, Michigan, our health system provided $550 million in community benefit in calendar year 2019. Thanks to the generosity of our communities, we received $37 million in philanthropy to support research, academics, innovation and clinical care. Spectrum Health has been recognized as one of the nation’s 15 Top Health Systems by Truven Health Analytics®, part of IBM Watson HealthTM.

Contact:
Tim Hawkins
Media Relations
Office: 616.486.6091
Mobile: 616.443.0361
Email: timothy.hawkins@spectrumhealth.org